The TB Alliance introduced that it includes unveiled a Phase II clinical trial "of the new therapy regimen for tuberculosis, such as for affected individuals who have the protection from existing multi-drug programs," Agency France-Press reports.
"The brand new regimen being examined could reduce necessary therapy to as cheap as four months in each of the affected individuals who have TB as well as some forms of drug-resistant TB, when compared to the current six to 24 months," the information company writes, adding, "Expenses is likewise greatly decreased." The trial "is going to take place at eight sites in South Africa, Tanzania, and Brazil, the alliance said," AFP notes (Santini, 3/19).
No comments:
Post a Comment